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FactSheet
Interim Guidance for Protecting Workers 
from Occupational Exposure to Zika Virus
The Occupational Safety and Health Administration (OSHA) and the National Institute 
for Occupational Safety and Health (NIOSH) are monitoring the impact of the Zika virus 
on U.S. states and territories, Central and South America, Mexico, and parts of the 
Caribbean. For the most up-to-date information, check the Centers for Disease Control 
and Prevention (CDC) Zika website frequently. 
Vectors that can transmit Zika virus are or have been previously found in U.S. territories 
and some U.S. states. Although active Zika virus transmission has been detected in 
some areas of the United States, most cases of Zika virus have been travel-associated. 
Workers who are exposed on the job to mosquitoes or the blood or other body fluids 
of infected individuals may be at risk for occupationally acquired Zika virus infection. 
This interim guidance provides employers and workers, including workers who are or 
may become pregnant or whose sexual partners are or may become pregnant, with 
information and guidance on preventing occupational exposure to the Zika virus. The 
guidance may be updated as additional information becomes available.
Introduction
Zika virus is primarily spread through the bites 
of infected mosquitoes. Mosquitoes can become 
infected when they bite infected people and can 
then spread the Zika virus to other people they 
subsequently bite. Many people infected with 
Zika virus won’t have symptoms or will only have 
mild symptoms; however, Zika infection during 
pregnancy can cause serious birth defects. 
Zika virus historically has been found in Africa, 
Southeast Asia, and the Pacific Islands. The first 
case was identified in the Zika Forest in Uganda in 
1947.1 In 2015, cases of Zika virus were reported in 
the Americas and the Caribbean.
Visit the CDC Areas with Zika website to learn 
where cases of local mosquito-borne transmission 
of Zika virus disease have been reported and where 
there is active transmission. 
Zika virus has the potential to spread anywhere 
that mosquitoes capable of transmitting the virus 
are found. Aedes species mosquitoes are the 
principal vectors (i.e., carriers) of Zika virus in the 
1. Hayes, Edward B. (1994). Zika Virus Outside Africa. Emerging 
Infectious Diseases, 15(9), 1347–1350.
U.S. Aedes aegypti (commonly known as yellow 
fever mosquitoes) are typically concentrated in the 
southern U.S. as well as parts of the Southwest. 
Another vector for Zika virus is Aedes albopictus 
(commonly known as Asian Tiger mosquitoes), 
which are found in much of the southern and 
eastern part of the U.S. Aedes aegypti mosquitoes 
are more likely to spread Zika, dengue and 
chikungunya viruses than are other mosquito 
species, including Aedes albopictus. CDC provides 
information about mosquito control, including the 
Aedes aegypti mosquitoes, like the one pictured, can become infected 
when they bite infected persons and can then spread the Zika virus to 















potential range of Aedes aegypti and Aedes 
albopictus in the U.S., on its website. In addition, 
meteorological conditions, the number of people 
travelling from areas with ongoing transmission, 
and socioeconomic factors play a role in Zika 
transmission in the contiguous U.S. (the lower 
48 states).2 For example, Aedes aegypti can thrive 
in many areas during summer months (July-
September) but are only active in winter months 
(December-March) in areas where temperatures do 
not fall below 10° C (50° F). The mosquitoes that 
spread Zika usually do not live at elevations above 
2,000 meters (6,562 feet).3 
Zika Virus Infection in Humans
Many people infected with Zika virus will not 
have symptoms or will only have mild symptoms. 
Exactly how often people have Zika virus infections 
without symptoms is not known. When people do 
experience symptoms, they usually begin about 
3-14 days after the bite of an infected mosquito, 
are usually mild, and typically last 2-7 days. The 
most common symptoms of Zika virus infection 
are fever, rash, joint pain and red or pink eyes. 
Other symptoms include myalgia (muscle pain) and 
headache. These symptoms are similar to those 
of dengue fever or chikungunya. Neurological and 
autoimmune complications are infrequent but 
have been described in outbreaks in Polynesia and, 
more recently, in the Americas. 
In most people, during the first 1-2 weeks of 
infection, Zika virus can be detected in the blood 
and is capable of being spread from an infected 
person to a mosquito that feeds on that person. 
Direct contact with infectious blood or other body 
fluids (such as semen through sexual contact or 
exposure by a needlestick or other sharps injury) 
of an infected person can result in transmission of 
the virus.
Zika virus can be spread from a pregnant woman 
to her fetus and is a cause of serious birth defects 
of the brain in fetuses and infants, which includes 
microcephaly and other problems. Other problems 
have been detected among fetuses and infants 
infected with Zika virus before birth, such as absent 
or poorly developed brain structures, defects of the 
eye, hearing deficits and impaired growth.
2. Monaghan, A. J., Morin, C. W., Steinhoff, D. F., Wilhelmi, 
O., Hayden, M., Quattrochi, D. A. & Scalf, P. E. (2016). On the 
seasonal occurrence and abundance of the Zika virus vector 
mosquito Aedes aegypti in the contiguous United States. PLoS 
Currents Outbreaks, 8(1).
3. Cetron, M. (2016). Revision to CDC’s Zika travel notices: 
Minimal likelihood for mosquito-borne Zika virus transmission 
at elevations above 2,000 meters. MMWR. Morbidity and 
Mortality Weekly Report, 65(10), 267-268.
Control & Prevention
CDC recommendations for preventing Zika virus 
infection, include special precautions, such as 
avoiding or delaying travel to Zika-affected areas 
for women who are or may become pregnant 
and for people with sexual partners who are or 
may become pregnant. In areas affected by Zika 
virus transmission, protect yourself and others 
from possible exposure to Zika virus by always 
taking steps to prevent mosquito bites. There is 
no approved vaccine to prevent Zika virus and 
there is no specific treatment for individuals who 
become infected.
Although Zika virus is primarily spread through 
the bites of infected mosquitos, exposure to an 
infected person’s blood or other body fluids (such 
as semen through sexual contact or exposure by a 
needlestick or other sharps injury) may also result 
in transmission. Employers should train workers 
about their risks of exposure to Zika virus through 
mosquito bites and contact with infectious blood 
and other potentially infectious materials and 
how to protect themselves. Employers should 
also provide information about the risk of Zika 
virus exposure and infection to workers who are 
pregnant or may become pregnant or whose 
sexual partners are or may become pregnant. 
For workers with potential exposure, this should 
include information on modes of transmission and 
the adverse birth outcomes caused by infection 
during pregnancy.
Depending on workers’ exposure, job tasks and 
the controls necessary to protect them, employers 
must comply with the provisions of applicable 
OSHA requirements, including:
• the Personal Protective Equipment (PPE) 
standards (29 CFR 1910 Subpart I and, for 
construction, 29 CFR 1926 Subpart E), such as 
when workers need wearable mosquito netting 
or other PPE; 
• the Bloodborne Pathogens (BBP) standard (29 
CFR 1910.1030), when workers have exposure to 
blood or other potentially infectious materials; 
and
• paragraph (b)(4) of the Safety Training and 
Education standard (29 CFR 1926.21) when 
construction workers are in job site areas where 
harmful animals are present (e.g., mosquitoes 
that could spread the Zika virus). 
Additional information for specific types of workers 
is below. Consult the CDC Zika website for the 
most up-to-date information to help employers 




• Inform workers about their risks of exposure to 
Zika virus through mosquito bites and train them 
on how to protect themselves. Check the CDC 
Zika website to find Zika-affected areas.
• Provide insect repellents, encourage their use, 
and train workers to use them according to the 
guidance below.
• Ensure that workers wear clothing that covers 
their hands, arms, legs and other exposed skin. 
Employers may need to provide workers with 
hats with mosquito netting to protect the face 
and neck.
• In warm weather, encourage workers to wear 
lightweight, loose-fitting clothing. This type 
of clothing protects workers against the sun’s 
harmful rays and can help prevent (although 
it may not fully prevent) mosquitoes from 
biting bare skin. Always provide workers with 
adequate water, rest and shade, and monitor 
workers for signs and symptoms of heat illness.
• Periodically inspect worksites to identify and 
get rid of sources of standing water (e.g., tires, 
buckets, cans, bottles, barrels, clogged gutters) 
whenever possible to reduce or eliminate places 
where mosquitoes lay their eggs. Train workers 
about the importance of eliminating these areas 
at the worksite.
• If requested by a worker who is pregnant or 
whose sexual partner is pregnant or may 
become pregnant, consider reassigning the 
worker to indoor tasks to reduce their risk of 
mosquito bites.
Recommended worker actions:
• Use insect repellents according to the guidance 
below. 
• Wear clothing that covers hands, arms, legs and 
other exposed skin. Wear hats with mosquito 
netting to protect the face and neck. Wear socks 
that cover the ankles and lower legs.
• In warm weather, wear lightweight, loose-fitting 
clothing. This type of clothing protects against 
the sun’s harmful rays and can help provide a 
barrier to mosquitoes. Consider spraying light 
weight, loose-fitting clothing with permethrin 
for additional protection. Drink plenty of water, 
take rest breaks in shaded areas and watch for 
signs and symptoms of heat illness, including 
in coworkers.
• Get rid of sources of standing water (e.g., tires, 
buckets, cans, bottles, barrels, clogged gutters) 
whenever possible to reduce or eliminate places 
where mosquitoes lay their eggs. 
• Talk to your supervisor(s) about any outdoor work 
assignment(s) if you are or may become pregnant 
or if your sexual partner is or may become 
pregnant. Such workers should be familiar with 
CDC information on Zika virus and pregnancy.
• If symptoms develop, seek medical attention 
promptly. Discuss any possible exposure to 
mosquitoes or infections spread by mosquitoes 
with a healthcare provider.
Guidance on use of insect repellents for employers 
and workers:
• Always follow label precautions when using 
insect repellent.
• Use insect repellent containing an EPA-
registered active ingredient. All of the EPA-
registered active ingredients have demonstrated 
repellency, but some provide longer-lasting 
protection than others. Research suggests 
that repellents containing DEET (N,N-diethyl-
m-toluamide) or picaridin (KBR 3023) typically 
provide longer-lasting protection than the 
other products, and oil of lemon eucalyptus 
(p-menthane-3,8-diol) provides longer-lasting 
protection than other plant-based repellents. 
Permethrin is another long-lasting repellent that 
is intended for application to clothing and gear, 
but not directly to skin.
• Choose a repellent that will protect against 
mosquito bites for the amount of time that you 
will be outdoors. In general, the more active 
ingredient (higher concentration) a repellent 
contains, the longer it will protect against 
mosquito bites. For example, the more DEET a 
repellent contains, the longer it can protect you 
from mosquito bites. If using DEET-containing 
products, choose one with at least 20 percent 
DEET as its active ingredient and re-apply every 
four hours. Note: Products with more than 50 
percent DEET may not offer a marked increase 
in protection.
• To avoid reaction to DEET or other ingredients in 
insect repellents, read and follow the directions 
on all insect repellents before use. 
• Spray insect repellent (permethrin) on the 
outside of clothing to help prevent mosquitoes 
from biting through clothing. Mosquitoes may 
be able to bite through thin clothing or clothing 
made of certain types of loosely woven fabrics. 
• Avoid spraying DEET on garments made of 
synthetic fabrics, as it may damage or dissolve 
the fabric.4
4. Fradin, M. S., & Day, J. F. (2002). Comparative efficacy of 
insect repellents against mosquito bites. New England Journal 
of Medicine, 347(1), 13-18.
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• Do NOT spray insect repellent on skin that is 
under clothing. 
• Do NOT apply insect repellent to skin that is 
already irritated, or to cuts/lacerations. 
• Do NOT spray aerosol or pump products in 
enclosed areas. Do NOT spray a pump or aerosol 
product directly on the face. First spray it on hands 
and then carefully spread it on the face (do not 
allow insect repellent to contact eyes or mouth). 
• After returning indoors and before eating, use 
soap and water to wash skin, such as the hands, 
arms, and face, that has been treated with insect 
repellent. Reapply repellent when returning 
outdoors or after eating.
• Outdoor workers may need to use sunscreen 
in conjunction with insect repellent. Repellents 
that are applied according to label instructions 
may be used with sunscreen with no reduction 
in repellent activity. However, limited data show 
a one-third decrease in the sun protection factor 
(SPF) of sunscreens when DEET-containing 
insect repellents are used after a sunscreen 
is applied. Products that combine sunscreen 
and repellent are not recommended, because 
sunscreen may need to be reapplied more 
often and in larger amounts than needed for the 
repellent component to provide protection from 
biting insects. The best option is to use separate 
products, applying sunscreen first and then 
applying the repellent. Due to the decrease in SPF 
when using a DEET-containing insect repellent 
after applying sunscreen, users may need to 
reapply the sunscreen more frequently.5
• Stop using insect repellent and/or sunscreen 
if a rash or other adverse symptoms develop. 
Wash skin with soap and water. Consult a 
healthcare provider or poison control center 
for further guidance. Be sure to inform the 
healthcare provider or poison control center 
about the insect repellent used (e.g., type, 
when and where applied). Take other actions 
described in this guidance to avoid mosquito 
bites if insect repellent cannot be used.
Healthcare and laboratory workers
Employers and workers in healthcare (including 
those who handle human remains) and biomedical 
laboratories (including clinical and research 
facilities) should follow required and recommended 
infection prevention and biosafety practices to 
prevent or minimize the risk of transmission of 
infectious agents (e.g., Zika virus). 
5. U.S. Department of Health and Human Services, Centers for 
Disease Control and Prevention, “CDC Health Information for 
International Travel, 2016 (Yellow Book).”
Employers must comply with applicable 
requirements in the BBP standard (29 CFR 
1910.1030) whenever workers may be exposed 
to human blood or other potentially infectious 
materials. Employers must also comply with 
OSHA’s PPE (29 CFR 1910.132) and Respiratory 
Protection (29 CFR 1910.134) standards, among 
other OSHA requirements.
In healthcare and when workers are handling human 
remains (regardless of suspected or confirmed Zika 
infection status), standard precautions are used to 
expand the universal precautions required by the 
BBP standard (29 CFR 1910.1030) whenever workers 
may be exposed to human blood or other potentially 
infectious materials. CDC-recommended standard 
precautions include hand hygiene, injection safety 
and the use of PPE to avoid direct contact with 
blood and other potentially infectious materials, 
including laboratory specimens/samples. 6 PPE may 
include gloves, gowns, masks, and eye protection. 
Hand hygiene consists of washing with soap and 
water or using alcohol-based hand rubs containing 
at least 60 percent alcohol.7 Soap and water are 
best for hands that are visibly soiled. Perform hand 
hygiene before and after any contact with a patient, 
after any contact with potentially infectious material 
and before putting on and promptly after removing 
PPE, including gloves. For workers with exposure 
to human blood and other potentially infectious 
materials, the BBP standard (29 CFR 1910.1030) 
requires hand washing after removal of PPE.
Laboratories should ensure that their facilities 
and practices meet the appropriate Biosafety 
Level (BSL) for the type of work being conducted 
(including the specific biological agents – in 
this case, Zika virus) in the laboratory. CDC has 
guidance for transporting specimens and working 
with Zika virus in the laboratory. The Biosafety 
in Microbiological and Biomedical Laboratories 
(BMBL), 5th Edition also provides detailed 
biosafety guidance for working with arboviruses, 
including Zika, in Section VIII – F: Arboviruses and 
Related Zoonotic Viruses. Laboratories should 
handle Zika virus at BSL-2, including limiting access 
to laboratories and other work areas when work 
is occurring and conducting certain procedures 
in biosafety cabinets or other containment 
6. Healthcare Infection Control Practices Advisory Committee, 
“2007 Guideline for Isolation Precautions: Preventing 
Transmission of Infectious Agents in Healthcare Settings,” 
Centers for Disease Control and Prevention (CDC), U.S. 
Department of Health and Human Services (HHS).
7. U.S. Department of Health and Human Services, Centers 
for Disease Control and Prevention, “Show Me the Science – 
When & How to Use Hand Sanitizer.”
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equipment. Some procedures may require BSL-3 
precautions, including additional respiratory 
protection, based on the risk assessment of 
the proposed work.8 The BMBL guidance also 
describes BSLs in Section IV - Laboratory Biosafety 
Level Criteria.
Additionally, employers should ensure that workers:
• Follow workplace standard operating 
procedures (e.g., workplace exposure control 
plans) and use the engineering controls and 
work practices available in the workplace to 
prevent exposure to blood or other potentially 
infectious materials. See 29 CFR 1910.1030.
• Do NOT bend, recap, or remove contaminated 
needles or other contaminated sharps. Properly 
dispose of these items in closable, puncture-
resistant, leakproof, and labeled or color-coded 
containers. See 29 CFR 1910.1030(d)(2)(vii) 
and (viii).
• Use sharps with engineered sharps injury 
protection (SESIP) to avoid sharps-related 
injuries. See 29 CFR 1910.1030(d)(2).
• Report all needlesticks, lacerations, and 
other exposure incidents to supervisors as soon 
as possible.
There is limited evidence that Zika virus may 
be transmitted through aerosol exposure in 
laboratories.9 Minimizing the aerosolization of 
blood or body fluids as much as possible during 
laboratory tasks will help prevent laboratory 
workers from being exposed to Zika virus and 
other pathogens. Although there is no evidence 
that the Zika virus spreads by aerosols in clinical 
settings, minimizing the aerosolization of blood or 
body fluids as much as possible during patient care 
tasks will help prevent healthcare workers from 
being exposed to Zika virus and other pathogens.
Employers should consider additional protections, 
including engineering controls to ensure containment 
of pathogens or enhanced PPE to prevent or reduce 
exposure where workers are at increased risk of 
exposure to Zika virus or other hazards (e.g. working 
with concentrated specimens of Zika virus).
Mosquito control workers
When working outdoors, follow the same 
precautions recommended above for 
general outdoor workers for protection 
against mosquito bites.
8. U.S. Department of Health and Human Services, “Biosafety in 
Microbiological and Biomedical Laboratories (BMBL), 5th ed.”
9. Scherer, W. F. (1980). Laboratory safety for arboviruses 
and certain other viruses of vertebrates. American Journal of 
Tropical Medicine and Hygiene, 29(6), 1359-1381.
Workers entering or working around areas with 
dense mosquito populations of Aedes mosquitoes 
likely will need enhanced skin protection to prevent 
mosquito bites. Employers should assess such 
workers’ risks of mosquito bites, provide any 
additional protective clothing or equipment to 
protect workers’ exposed skin and ensure workers 
wear or use it correctly.
Workers who mix, load, apply or perform other 
tasks involving wide-area (or area) insecticides may 
need additional protection to prevent or reduce 
exposure to hazardous chemicals. These protections 
include pesticide safety training, notification of 
pesticide applications, PPE (potentially including 
respirators), restricted entry intervals after pesticide 
application, decontamination supplies and access 
to emergency medical assistance. The EPA 
Agricultural Worker Protection Standard (WPS), 
which regulates pesticide safety, and the EPA WPS 
page provide more information about these types 
of protections. Although the WPS is a regulation for 
agricultural pesticides aimed at reducing the risk of 
pesticide poisonings and injuries among agricultural 
workers and pesticide handlers, its requirements 
may provide a model for protecting workers using 
insecticides in mosquito control operations. 
Employers also must comply with any applicable 
requirements in OSHA’s PPE standards (29 CFR 
1910 Subpart I), including when workers need 
gloves or eye protection, among other OSHA 
requirements. Respirators must be used in 
accordance with the respirator selection, medical 
clearance, fit-testing and other requirements 
of OSHA’s Respiratory Protection standard (29 
CFR 1910.134). Employers should monitor the 
use of respirators by any worker who must 
drive vehicles (e.g., trucks used for insecticide 
application) to ensure that respirator use does 
not restrict the worker’s ability to operate the 
vehicle safely. OSHA’s Safety and Health Topics 
page on Respiratory Protection provides general 
information on respirator use and OSHA standards 
that may apply to the use of chemicals.
Suspected or Confirmed Zika: General 
Guidance for Workers and Employers
CDC advises individuals, including workers, 
infected with Zika virus to10:
• Get plenty of rest.
• Drink fluids to prevent dehydration.
10. U.S. Department of Health and Human Services, Centers 
for Disease Control and Prevention, “Zika Virus – Symptoms, 
diagnosis, & Treatment.”
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• Take medicine such as acetaminophen to reduce 
fever and pain.
• Do not take aspirin, ibuprofen, naproxen, or 
other non-steroidal anti-inflammatory drugs 
unless your healthcare provider tells you it is 
okay to do so. These medications can increase 
the risk of bleeding if your symptoms are caused 
by infection with dengue virus. 
• Talk to a healthcare provider before taking any 
other medications, including prescriptions, for 
other medical conditions.
• To help prevent others from getting sick, avoid 
mosquito bites during the first week of infection. 
Wearing clothing that covers skin and using 
insect repellents can help prevent mosquito bites. 
• To help prevent transmission to partners via 
sexual contact, abstain from vaginal, anal and 
oral sexual activity, or use condoms correctly 
every time you have sex. See the CDC Zika 
and Sexual Transmission website and the CDC 
Testing for Zika website for more information. 
Employers should:
• Ensure that supervisors and all potentially 
exposed workers are aware of the symptoms 
of Zika. 
• Train workers to seek medical evaluation if they 
develop symptoms of Zika.
• Assure that workers receive prompt and 
appropriate medical evaluation and follow-up 
after a suspected exposure to Zika virus. If the 
exposure is to human blood or other potentially 
infectious materials and falls under OSHA’s BBP 
standard (29 CFR 1910.1030), employers must 
comply with medical evaluation and follow-
up requirements in the standard. See 29 CFR 
1910.1030(f).
• Consider options for granting sick leave during 
the infectious period. CDC describes steps 
employers and employees can take to protect 
others during the first week of Zika virus illness. 
Section 11(c) of the Occupational Safety and 
Health Act, 29 USC 660(c), prohibits employers 
from retaliating against workers for such things 
as raising concerns about safety and health 
conditions. OSHA encourages workers who 
suffer such discrimination to submit a complaint 
to OSHA. Workers have 30 days from an alleged 
reprisal to file their complaints.
Travel to Zika-affected areas
CDC recommends that pregnant women in any 
trimester not travel to an area with active Zika virus 
transmission. Employers should consider allowing 
flexibility in required travel, including delaying 
travel to Zika-affected areas, for workers who are 
concerned about Zika virus exposure and especially 
for workers who are or may become pregnant 
or whose sexual partners are or may become 
pregnant. Flexible travel and leave policies may help 
control the spread of Zika virus, including to workers 
who are concerned about reproductive effects 
potentially associated with Zika virus infection.
When traveling to or through Zika-affected areas, 
follow the precautions described in the “Control 
and Prevention” section for specific work activities. 
CDC guidance for travel to Zika-affected areas may 
also help employers and workers in travel-related 
operations, such as airline crew members and cruise 
line workers, to take appropriate protective actions.
CDC has published Zika Travel Information by 
region, which may assist workers and employers 
in making travel-related decisions or implementing 
precautions when traveling. Pregnant women, 
women who may become pregnant and people with 
sexual partners who are or may become pregnant 
should consult with their healthcare providers about 
risks associated with Zika virus infection during 
pregnancy. More information can also be found on 
the CDC Zika and Pregnancy website.
Travelers who have traveled to an area with Zika 
can use condoms or not have sex to protect their 
sexual partners. Women should consider using 
condoms every time they have sex or should not 
have sex for at least eight weeks after symptom 
onset (if symptomatic) or last possible exposure 
(if asymptomatic). Men should use condoms every 
time they have sex or should not have sex for at 
least six months after symptom onset (if they 
have symptoms) or last possible exposure (if no 
symptoms) to protect their sex partners; this period 
is longer for men because Zika stays in semen longer 
than in other body fluids. Women and men who 
have a pregnant sex partner should consistently 
and correctly use condoms to prevent Zika virus 
infection every time they have sex or should not 
have sex for the duration of the pregnancy. Even if 
they do not feel sick, travelers returning to the U.S. 
from an area with Zika should take steps to prevent 
being bitten by mosquitoes for three weeks so they 
do not pass Zika to mosquitoes that could spread 
the virus to other people. CDC provides information 
on mosquito bite prevention for travelers.
Additional Resources
• Zika Virus. Centers for Disease Control and 
Prevention (CDC), U.S. Department of Health 
and Human Services (HHS).
• Zika Travel Information. Centers for Disease 
Control and Prevention (CDC), U.S. Department of 
Health and Human Services (HHS).
7
• Zika Virus Protection for Outdoor Workers. 
Occupational Health and Safety Administration 
(OSHA), U.S. Department of Labor.
• Zika: Protecting US Businesses and Business 
Travelers. National Institute for Occupational 
Safety and Health (NIOSH), Centers for Disease 
Control and Prevention (CDC), U.S. Department 
of Health and Human Services (HHS).
• Zika: Protecting Healthcare and Laboratory 
Workers. National Institute for Occupational 
Safety and Health (NIOSH), Centers for Disease 
Control and Prevention (CDC), U.S. Department of 
Health and Human Services (HHS).
• Zika: Protecting Outdoor Workers. National 
Institute for Occupational Safety and Health 
(NIOSH), Centers for Disease Control and 
Prevention (CDC), U.S. Department of Health 
and Human Services (HHS).
• Laboratory Safety when Working with Zika 
Virus. Centers for Disease Control and 
Prevention (CDC), U.S. Department of Health 
and Human Services (HHS).
• Mosquito-Borne Diseases. National Institute 
for Occupational Safety and Health (NIOSH), 
Centers for Disease Control and Prevention 
(CDC), U.S. Department of Health and Human 
Services.
• Zika Virus Fact Sheet. World Health Organization 
(WHO).
• Zika virus infection and Zika fever: Frequently 
Asked Questions. Pan American Health 
Organization (PAHO).
• Mosquito Bite Prevention for Travelers (PDF). 
Centers for Disease Control and Prevention 
(CDC), U.S. Department of Health and Human 
Services (HHS).
• Zika information repository. Center for Infectious 
Disease Research and Policy (CIDRAP), 
University of Minnesota.
• Rodents, Snakes and Insects QuickCard. 
Occupational Safety and Health Administration 
(OSHA), U.S. Department of Labor (DOL).
• 2007 Guideline for Isolation Precautions: 
Preventing Transmission of Infectious Agents in 
Healthcare Settings (PDF). Healthcare Infection 
Control Practices Advisory Committee (HICPAC), 
Centers for Disease Control and Prevention 
(CDC), U.S. Department of Health and Human 
Services (HHS).
• Safety and Health Information Bulletin: 
Workplace Precautions Against West Nile Virus. 
Occupational Safety and Health Administration 
(OSHA), U.S. Department of Labor (DOL). 
Provides related guidance for workers and 
employers that is also generally applicable to 
Zika virus and other mosquito-borne diseases.
• West Nile Virus Fact Sheet (PDF*). Occupational 
Safety and Health Administration (OSHA), U.S. 
Department of Labor (DOL). Provides related 
guidance for workers and employers that is 
also generally applicable to Zika virus and other 
mosquito- borne diseases.
• West Nile Virus QuickCard. Occupational 
Safety and Health Administration (OSHA), U.S. 
Department of Labor (DOL). Provides related 
guidance for outdoor workers that is also 
generally applicable to Zika virus and other 
mosquito-borne diseases.
• Surveillance and Control of Aedes aegypti and 
Aedes albopictus in the United States. Centers 
for Disease Control and Prevention (CDC), 
U.S. Department of Health and Human Services 
(HHS).
• Bloodborne Pathogens and Needlestick 
Prevention Safety and Health Topics. 
Occupational Safety and Health Administration 
(OSHA), U.S. Department of Labor (DOL).
• West Nile Virus Prevention. National Institute 
for Occupational Safety and Health (NIOSH), 
Centers for Disease Control and Prevention 
(CDC), U.S. Department of Health and Human 
Services (HHS). Provides related guidance for 
workers and employers that is also generally 
applicable to Zika virus and other mosquito- 
borne diseases.
• Fast Facts: Protecting Yourself from Ticks 
and Mosquitoes (PDF). National Institute for 
Occupational Safety and Health (NIOSH), 
Centers for Disease Control and Prevention 
(CDC), U.S. Department of Health and Human 
Services (HHS).
• Heat Stress Topic Page. National Institute 
for Occupational Safety and Health (NIOSH), 
Centers for Disease Control and Prevention 
(CDC), U.S. Department of Health and Human 
Services (HHS).
• Fast Facts: Protecting Yourself from Heat Stress 
(PDF). National Institute for Occupational Safety 
and Health (NIOSH), Centers for Disease Control 
and Prevention (CDC), U.S. Department of Health 
and Human Services (HHS).
• Respirator Topic Page. National Institute for 
Occupational Safety and Health (NIOSH), 
Centers for Disease Control and Prevention 
(CDC), U.S. Department of Health and Human 
Services (HHS).
• Preventing Transmission of Zika Virus in Labor 
and Delivery Settings Through Implementation 
of Standard Precautions – United States, 2016. 
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